COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Click to access mobile menu
  • Share:

ODS Strategic Plan 2017-2021

Office of Dietary Supplements Strategic Plan 2017-2021  

ODS’s 5-year strategic plan is based on a review and assessment of ODS program objectives and accomplishments that correlate directly to ODS’s stated mission, goals and key emerging public health issues. The current strategic plan covers the 2017-2021 time period (see PDF on left).

To ensure that ODS continues to meet its objectives while responding to emerging public health issues through the 5-year period, ODS  began using an annual reporting structure in 2016. The annual report also provides key stakeholders with transparency into ODS activities. This 2018 report includes an abbreviated presentation of key program accomplishments and illustrates how ODS staff work together across their programs to meet ODS’s mission and goals.

Joseph Betz, Ph.D., Acting Director
Office of Dietary Supplements
National Institutes of Health

Office of Dietary Supplements Strategic Plan Annual Report January – December 2018

The history of ODS is rooted in legislation by the U.S. Congress that forms the basis of the ODS mission and activities. ODS was created in 1995 at NIH to meet the requirements of the Dietary Supplement Health and Education Act (DSHEA) of 1994. According to DSHEA, the purpose of ODS is to explore the role of dietary supplements as a significant part of the efforts of the United States to improve health care and to promote scientific study of dietary supplements in maintaining health and preventing chronic disease. Since its inception, several congressional mandates have directed ODS to add new or enhance existing activities including to establish a botanical research center program (1999), conduct evidence-based reviews of the efficacy and safety of dietary supplements (2001), accelerate the validation of analytical methods and reference materials for dietary supplements (2002), and develop a dietary supplement label database (2004).

Exhibits 1, 2, and 3 below summarize the ODS mission, goals, and areas of focus.

Exhibit 1: ODS Mission, Goals, and Areas of Focus; The mission of ODS is to support, conduct, and coordinate scientific research and provide intellectual leadership for the purpose of strengthening the knowledge and understanding of dietary supplements to foster an enhanced quality of life and health for the U.S. population. DSHEA Mandate 1-4: 1. Conduct and coordinate scientific research within NIH relating to dietary supplements. 2. Coordinate funding relating to dietary supplements for the NIH. 3. Collect and compile the results of scientific research relating to dietary supplements; develop a database. 4. Serve as the principal advisor to HHS on issues relating to dietary supplements.  ODS Goals 1-4: 1. Support and Stimulate Dietary Supplement Research (spans DSHEA Mandates 1-3). 2. Support and Conduct Training (Mandate 1). 3. Develop and Disseminate Resources (Mandates 3-4). 4. Translate Dietary Supplement Research for All (Mandates 3-4). ODS Area of Focus (AF) 1: Research and Training (supports goals 1-2). AF 2: Population and Nutrient Initiatives (goal 1). AF 3: Research Resources (goal 3). AF 4: Collaborations with Federal Agencies (goals 1-3). AF 5: Translating Research Findings (goal 4).

The responsibilities delineated by DSHEA are directly addressed by at least one of the four main ODS goals presented in Exhibit 2.

Exhibit 2: ODS Goals
Goal 1:  Expand the scientific knowledge base on dietary supplements by stimulating and supporting a full range of biomedical research and by developing and contributing to relevant initiatives, workshops, meetings, and conferences.
Goal 2: Enhance the dietary supplement research workforce through training and career development.
Goal 3: Foster development and dissemination of research resources and tools to enhance the quality of dietary supplement research.
Goal 4: Translate dietary supplement research findings into useful information for consumers, health professionals, researchers, and policymakers.

Exhibit 3 presents an organization of ODS’s 16 programs and activities and their primary categorization within one of ODS’s areas of focus (research and training, population and nutrient initiatives, collaborations, research resources and communications). While the overall emphasis of each program or activity relates to its assigned area of focus, there is frequent collaboration. In fact many programs or activities could be included in more than one area of focus.

Exhibit 3: Areas of Focus and Related Programs and Activities; Area of Focus (AF) 1: Research and Training; contains: Dietary Supplement Research, CARBON*, Training & Career Development, Dietary Supplement Research Practicum. AF 2: Population and Nutrient Initiatives; contains: Nutrient Initiatives for Vitamin D, Folate, Vitamin B12, Iron, and Iodine, Develop Tools/Analytical Models for Population Studies, and IEM/Primary Mitochondrial Diseases. AF 3: Research Resources; contains: AMRM*, Dietary Supplement Databases*, and Systematic Reviews*. AF 4: Collaborations with Federal Agencies; contains: Federal Working Group on Dietary Supplements and NIH/Federal Agency Collaborations & Consultations. AF 5: Translating Research Findings; contains: Communications, Publich Health Policy & Clinical Practice, Workshops, and Publications & Presentations. * = Congressionally Mandated Program

Innovation and Collaboration

As the lead federal entity addressing the scientific exploration of dietary supplements, ODS continues to advance the research agenda and knowledge base. The key to ODS’s success is the balance it achieves between its roles as a facilitator of research, developer of resources, trainer of researchers, collaborator with academics and Federal and other agencies, and communicator of existing and new knowledge.

The ODS Strategic Plan 2017–2021 provides a detailed description of each of the 16 ODS programs and activities that fall into the categories depicted in Exhibit 2 above. However, the reality of the work done by ODS and its programs is not so neatly categorized. Programs tend to be interwoven between areas of focus, satisfying different goals, and the collaborative nature of ODS staff helps to build strong connections within ODS, NIH, Federal agencies, academic institutions and other stakeholders within the dietary supplement community.

The following are 3 examples of how ODS staff have worked together across their programs and activities to achieve the overall mission and goals as stated above.

Training Early Career Scientists: ODS Scholars Program

female scientist

The ODS Research Scholars Program is a one-year competitive scholarship opportunity for NIH early career intramural scientists to study the role of dietary supplements and/or their ingredients in health promotion and disease prevention. Twenty-two scholars have participated in this program since it was established by ODS in 2014. Research performed by the ODS scholars has included pre-clinical, clinical, behavioral, and epidemiological research. Primary consideration for support has been given to proposals that stimulate dietary supplement research where it is lacking or lagging to clarify gaps, investigate the balance between health benefits and risks where data are in conflict, target special population groups where additional science on supplements is needed, and focus on the use of supplements and/or their ingredients in improving or maintaining health and reducing the risk of chronic disease. Another funding priority for this program is to enhance collaborations between multidisciplinary researchers from different NIH laboratories or institutes and ODS encourages applications where the scholar would have the opportunity to learn and apply new methodology to his or her research. A listing of ODS scholars, their mentors, and the titles of their funded research can be found on the ODS website.

In January 2019, an evaluation of the program was conducted to inform ODS about the efficiency and effectiveness of the funding and award processes used. All 22 ODS scholars who have participated in the program were invited to complete an online survey. The 13 respondents represented participants across all five years of the programs (2014-2018) and from six of the eight NIH Institutes and Centers with which ODS scholars have been affiliated. Overall, respondents appreciated the program as an opportunity to improve their research skills and to make collaborations that otherwise would not have been possible. Most scholars had no difficulties with the application process and appreciated ODS’s clear communications about the scholars’ research interests in the application process. The respondents reported they were pleased with the connections and collaborations they were able to make because of the program. Although most were new to the field of dietary supplements, the program appears to have piqued their interest in the field with many planning to pursue more dietary supplement research funding. A healthy majority (85 percent) thought that they were likely or very likely to pursue dietary supplement research in the future.

Translating Research Findings: A Workshop on Natural Product Clinical Trials

St. Johns Wort

Randomized, clinical trials (RCT) are the generally accepted gold standard for determining the effects of a food, drug or other intervention on human health. The high cost of an RCT demands that each trial be carefully designed to optimize the value of information obtained from it. Many natural products (NP) including foods, dietary supplements (DS), and individual components in foods and DS have been tested in RCT for effects on health, but the majority of these trials have not provided clear evidence of benefit (as is true for RCT overall). While “negative” RCT may be highly informative and useful for individual and public health, many of the DS trials were met with post-trial concerns that the failure to show benefit was a result of an insufficient evidence-base for rigorous trial design. Moreover, in some cases RCT results have failed to replicate, leaving stakeholders unsure which results to trust.

Recognizing an opportunity to address these issues and challenges across multiple scientific disciplines, ODS staff collaborated broadly with partners at NIH (NIA, NIAAA, NCI, and NCCIH), FDA and USDA, and colleagues from universities around the world to organize a workshop held in September 2018. The “Enhancing Natural Product Clinical Trials” workshop brought together experts in the many subdisciplines that must collaborate to generate a rigorously designed NP RCT, with an ultimate goal of strengthening the supporting data for such trials and increasing the likelihood of obtaining more actionable information from future NP RCT. Workshop participants emphasized that reproducibility and likelihood of successful translation of NP research from “bench” to human health depends on rigor throughout the supporting data for all aspects of the RCT, in the trial design and interpretation, and in the complete, accurate and transparent reporting of all components of the research. Discussions highlighted good practices for NP characterization and standardization, the use and interpretation of valid models (computational through in vivo), controls for experimental artifacts, the rigorous assessment and appropriate interpretation of prior research (ranging from ethnobotany and epidemiology through the various preclinical model systems to prior clinical research), and in transparency and research prioritization.

Articles summarizing the workshop discussions are in preparation. The dissemination and implementation of practices highlighted at the workshop should strengthen the foundations for future NP RCT design and prioritization decisions and enhance knowledge gained from discrepancies between hypothesized and observed outcomes in future trials.

Quality Assurance Programs: Increasing Rigor and Reproducibility

The precise, accurate, and reliable measurement of nutrients, elements, botanical constituents, and their metabolites is essential to the establishment of a rigorous and reproducible foundation for biomedical research on dietary supplements and nutrition. The ODS Analytical Methods and Reference Materials (AMRM) Program aims to address this need through multiple activity areas, such as promoting the development and validation of innovative quantitative methods and the production of calibration standards and reference materials for use in public health research and the assessment of dietary supplement composition.

In addition, the AMRM Program funds the administration of laboratory quality assurance programs (QAPs) that provide research scientists, clinical labs, industry analysts, and regulators a means to evaluate their measurement systems and capabilities, identify and resolve problem areas, and improve performance and harmonization across analytical communities. Participants of AMRM-supported QAPs measure nutrients, phytochemicals, and related metabolites in food, dietary supplement, and serum or plasma samples distributed by the National Institute of Standards and Technology (NIST). Participant data are compiled and analyzed for accuracy and precision against NIST measurements and assessed for concordance within the group of participants for each exercise. Technical performance reports are sent to participants, and one-on-one troubleshooting and joint meetings are used to promote methodological advancement and support training in health assessment measurements.

Historically, AMRM has funded QAPs that focused on the needs of specific analytical communities. A Dietary Supplement Laboratory QAP saw participation from many industry and third-party testing labs, and exercises facilitated improvements in the measurement reliability for vitamins, minerals, botanical constituents, and contaminants in supplement ingredients and products. A Vitamin D Metabolites QAP helped to reduce vitamin D status measurement bias among clinical labs and contributed to an international effort to establish accuracy-based laboratory performance monitoring. A Fatty Acids in Human Serum/Plasma QAP identified areas of significant measurement bias among research and clinical labs when quantifying long chain omega 3 fatty acids. In 2018 these and other NIST QAPs were consolidated into the newly organized Health Assessment Measurements QAP in 2018 to improve administrative coordination and efficiency in data analysis. A major goal of this evolving approach to the AMRM-funded QAP is to an effort to increase the responsiveness and flexibility of QAPs to address emerging public health issues and to better inform dietary supplement and nutrition research. Additionally, ODS and NIST are currently pursuing QAP-based exercises as an approach to accelerate analytical method validation and methodological comparability studies, and thus as a means to further meet the needs of analytical community stakeholders and accomplish the AMRM mission.

ODS Accomplishments

ODS's staff initiates effective collaborations across government and constituent communities. Such collaborations are key to fulfilling the ODS mission. The value of ODS efforts is evident in its ability to engage and manage the wide range of expertise required to accomplish its goals. The following are key 2018 ODS accomplishments as they reflect ODS’s strategic plan goals.

GOAL 1: Expand the scientific knowledge base on dietary supplements by stimulating and supporting a full range of biomedical research and by developing and contributing to relevant initiatives, workshops, meetings, and conferences. 
pills multicolor

  • ODS co-funded 61 grants for new and continuing projects valued at $10.3 million across 12 NIH Institutes and Centers.
  • ODS supports the Centers for Advancing Research on Botanical and Other Natural Products (CARBON) Program, run jointly by ODS and the National Center for Complementary and Integrative Health (NCCIH). The CARBON Program is responsible for 22 new publications in 2018.
  • ODS has increased the understanding of the microbiome with respect to food, dietary supplements, nutritional status, energy balance, and risk of disease. ODS co-funded one administrative supplement related to the microbiome, gave presentations on the microbiome at academic institutions and participated in three trans-NIH and trans-federal working groups related to the microbiome.
  • ODS staff collaborated with various NIH Institutes and Centers and other Federal agencies (CDC, HHS Office of the Secretary, FDA. and USDA) on obtaining accurate data on supplement usage and total nutrient intake from food and supplements in pregnant and lactating women, and infants up to 24 months.
  • New analyses have been undertaken to describe supplement usage in children less than 24 months of age in the 2007-2014 NHANES. Information in two pending publications describes each type of supplement by age group, trends over time and by breastfeeding status.
  • ODS staff worked closely with CDC and NHANES staff to determine how best to evaluate biomarkers for iodine status in pregnant women, infants, and children.
  • ODS staff are collaborating with the NHANES laboratory on the development of new biomarkers of red blood cell folate and an omega-3 fatty acid index.  These assays (funded in part by ODS) will be implemented in the 2019-2020 NHANES blood collections for all participants 1 year of age and older.
  • ODS staff are collaborating with the NHANES laboratory on the development of a method for measuring iron status and inflammation using a low volume of blood.  This assay will be used in the pilot test of bloods from children less than one year of age in the 2019 NHANES and possibly for the National Children’s Study blood samples being evaluated for pregnancy iron status screening.
  • ODS is collaborating on obtaining pregnancy dietary measures in several new cohorts.  The Environmental Influences on Child Health Outcomes (ECHO) will be launching 19 new cohorts and ODS staff, together with others are NIH, are encouraging collection of dietary and supplement data in these cohorts.   There are a series of existing cohorts in ECHO that will be merged and harmonized so that analyses can be conducted on dietary supplement use across time and geographic regions.
  • ODS staff participate in the Obesity-Diet and Nutrition Task Force telephone calls for ECHO and provide some input on their current analysis plans. The Division of Nutrition, Physical Activity and Obesity at the CDC in Atlanta is planning a study entitled “Infant Feeding Practices III” and they have been encouraged to collect dietary data during the pregnancy as well as during lactation.
  • New analyses have been undertaken to describe supplement usage in children less than 24 months of age in the 2007-2014 NHANES.   Information is described for each type of supplement by age group, trends over time and by breastfeeding status.  This analysis found that the majority of exclusively breastfed babies 0-5 months were not being given Vitamin D and those over 4 months of age were not given supplementary iron as recommended by the American Academy of Pediatrics.
  • ODS will be launching the Health & Resiliency Studies Program. The program will focus on elucidating biochemical mediators of resilience to help gain a better understanding of how physiologic adaptations to biological, environmental, and psychosocial stressors may impact nutrient status and overall health status in individuals. Research investigations that aim to identify biomarkers of health (to complement current biomarkers of disease) and clarify mechanisms of resiliency will be encouraged.
  • ODS co-sponsored, “Examining Special Nutritional Requirements in Disease States: A Workshop.”  The workshop was organized by an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine and was convened on April 2, 2018 – April 3, 2018.  Presentations and discussions focused on the evidence for special nutritional requirements in disease states and medical conditions that cannot be met with a normal diet. Available evidence that show how nutritional interventions affect the overall clinical management of diseases in terms of patient safety, efficacy, and access were also explored.
  • ODS co-sponsored the “Workshop for the Committee to Review the Dietary Reference Intakes for Sodium and Potassium.”  The workshop was organized by an ad hoc committee of the Food and Nutrition Board of the National Academies of Sciences, Engineering, and Medicine and was convened on March 7, 2018- March 9, 2018.  The workshop focused on the physiology of sodium and potassium on the kidney and vascular system as well as methodology issues related to measuring sodium and potassium intake. Health consequences of sodium and potassium exposure were discussed in the context of establishing or updating dietary reference intakes.
  • ODS co-sponsored a Food Forum hosted by the National Academies of Sciences, Engineering, and Medicine on December 5, 2017.  The forum titled, “Nutrigenomics and the Future of Nutrition,” focused on the application of nutrigenomics as a potential tool to better integrate population-based and personalized dietary guidance.  The interrelationships of diet, genomics, and health outcomes with respect to chronic disease endpoints were discussed.
  • ODS and the National Center for Complementary and Integrative Health (NCCIH) co-sponsored The NIH Centers for Advancing Research on Botanical and Other Natural Products (CARBON) Program Annual Meeting on May 21-22, 2018.  The CARBON Program comprises of three Botanical Dietary Supplements Research Centers (BDSRC) and the two Centers for Advancing Natural Products Innovation and Technology (CANPIT).  Highlights from the three BDSRC included presentations on “Botanicals and Metabolic Resiliency,” “Dietary Botanicals in the Preservation of Cognitive and Psychological Resilience,” and “Botanical Dietary Supplements for Women’s Health.”  Highlights from the two CANPIT included presentations on “High-Throughput Functional Annotation of Natural Products,” and “Natural Products Technologies.”  In addition to the meeting providing opportunities for awardees of the CARBON Program to present research updates, enhance collaborations, and participate in roundtable discussions for improving the state of the science on the effectiveness, safety, and mechanisms of action of botanicals and other natural products; the meeting also stimulated expert engagement on two themes: 1. Multi-component Contributions to Botanical Bioactivities and 2. Contribution of Gut Microbiota to Generating Bioactivities of Orally consumed Botanicals.
  • A workshop, “Enhancing Natural Product Clinical Trials”, led by ODS, with participation and/or input from FDA, USDA, NCI (Office of Cancer CAM and Nutrition Science Research Group), NIA, NIAAA, NIEHS, and ORWH, as well as many extramural researchers and industry participants, was held at NIH on September 13 and 14, with more than 300 participants registered to attend in person, and many more attending via webcast. The workshop speakers and attendees discussed good practices in generating and evaluating data used in the design and interpretation of clinical trials of natural products, as well as good practices in planning and designing such trials.

GOAL 2: Enhance the dietary supplement research workforce through training and career development. 

  • Among the 61 funded grants mentioned above, in FY2018 ODS funded 6 applications for the 2019 ODS Scholars Program, along with 21 administrative supplements and 3 single laboratory validation administrative supplements. These allow investigators, including junior scientists, to expand the scientific scope of their NIH-funded projects to include work related to dietary supplements. The CARBON program contributed directly to the training of 26 post-docs, 28 grad students, 2 undergraduate trainees, and one visiting international fellow.
  • ODS again offered its Dietary Supplement Research Practicum, a 2.5-day course to provide fundamental knowledge of dietary supplements to 90 academic faculty, Ph.D. students, and postdocs; healthcare practitioners; and other professionals with advanced biomedical degrees. Topics covered included: supplement use in the US and reasons for use, the regulatory framework governing supplements, differences in bringing foods, drugs, and supplements to the market, supplement quality, assessing the health effects of foods and supplements, and developing policies and advice about supplement use based on science. 
  • Through the AMRM program ODS is supporting, mentoring or providing technical guidance to 5 postdoctoral researchers at NIST and has made travel funding available for applicants, who had performed method validation studies supported Administrative Supplements, to present their work at the 2018 AOAC International Annual Meeting and Expo in August 2018.

GOAL 3: Foster development and dissemination of research resources and tools to enhance the quality of dietary supplement research.

  • As part of the ODS Analytical Methods and Reference Materials program (AMRM) contract with AOAC International for method development and validation, AOAC International convened the final Stakeholder Panel on Dietary Supplements for ODS’s contract for a method validation infrastructure in August 2018. At its conclusion, this effort resulted in 16 Official Methods of Analysis (First Action status) and 33 Standard Method Performance Requirement publications.
  • As part of an ongoing interagency collaboration between AMRM and the National Institute of Standards and Technology (NIST), ODS support permitted NIST scientists to develop new analytical methods for dietary supplements and allowed them to create and maintainapproximately 30 dietary supplement-specific matrix-based and calibration solution Standard Reference Materials (SRMs) throughout FY2018, including 8 newly issued or updated SRMs.
  • NIST finalized reports for the two final Dietary Supplement Quality Assurance Program (DSQAP) exercises.  Participant data for the first two Health Assessment Measurements Quality Assurance Program (HAMQAP) exercises, designed to better serve the needs of clinical researchers and industry analysts, are currently being analyzed.
  • AMRM funding, through an interagency agreement between ODS and the Food Composition and Methods Development Laboratory at USDA, has resulted in the development of innovative methods to identify, authenticate, and characterize botanical supplements including echinacea, black cohosh, and maca.
  • The CARBON program supported the development of 10 new methods.
  • Discussions were held related to biomarkers for iodine status and how best to measure them in pregnant women, infants and children and other at-risk groups such as minorities and individuals with dietary habits that minimize intake of iodine-rich food sources. Three letters of intent (LOI) were sent for NHANES 2019-2020 that included biological measures for iron and iodine status in pregnant and lactating women and infants age birth to 24 months.  Biomarkers of inflammation were also added to the LOI.
  • ODS staff worked with the Planning Branch at NHANES to develop a method to collect accurate infant and toddler formula information.  Beginning in 2019, the household interview will include collection of exact formula information from the label of currently consumed formula.  A database with formula composition will be developed at NHANES, similar to the dietary supplement database. The data collection module has been tested with interviewers and training has begun for data collection starting in January 2019. 
  • Work continues on an Interagency Agreement, initiated with the US Department of Agriculture Nutrient Data Laboratory, which aims to develop a database on the iodine content of salt, foods, beverages, and dietary supplements.  Activities will include studies on the stability of iodine in table salt, evaluation of iodine in commonly eaten foods, and in collaboration with CDC Atlanta, assessment of iodine content of standard dairy products and non-dairy “milks” made from nuts, grains, or legumes. Outputs will include addition of iodine values to the USDA Standard Reference Database, the Dietary Supplement Ingredient Database, and related databases as used for NHANES and other surveys.
    laboratory glassware

  • The DSLD added 1,000 new labels per month, reaching 86,000 labels by the end of 2018. The DSLD is accessible through both a desktop and mobile website version. There were 90,400 visits to the DSLD website throughout 2018.
  • Over 22 papers and presentations were prepared throughout the year using data available in the DSLD. Staff published a journal supplement about federal dietary supplement databases in the Journal of Nutrition in August 2018. It included four papers on the content, use cases, and recent updates to DSLD. Additionally, staff prepared an open access review in Nutrients (2018) that summarizes DSLD and how it has been used for research purposes. Staff have presented at over 15 scientific conferences and completed over 10 additional publications using DSLD data.
  • The Journal of Nutrition supplement on US Government Dietary Supplement Databases was edited by ODS staff and published in the summer of 2018 and included many papers on the use of data that is available in DSID.
  • ODS supported DSID analyses of dietary supplement product disintegration and dissolution, (performance testing not required for dietary supplements) to highlight knowledge gaps in these formulation attributes and in current analytical methods.
  • Along with presentations, ODS staff have completed two journal supplements. The Nutrients journal special issue on dietary supplements will include papers on iodine, vitamin D, omega-3, iron, and on scientific and regulatory challenges in dietary supplement research. For the Journal of Nutrition, a supplement to be published in early 2018 was prepared (along with Federal partners) to include seven papers on dietary supplement databases.
  • Over 600 FY 2017 projects were reviewed, coded and published in CARDS and almost 800 FY 2018 projects downloaded from IMPAC II.

GOAL 4: Translate dietary supplement research findings into useful information for consumers, health professionals, researchers, and policymakers.

  • ODS prepared new fact sheets on pantothenic acid and potassium (for both health professionals and consumers), niacin (for health professionals), and on dietary supplements for mitochondrial disorders (for health professionals). The fact sheets on folate (for health professionals and consumers) were completely revised and updated. Also, the fact sheets on omega-3 fatty acids (for health professionals and consumers) were updated with new information.
  • In 2018, visits to the ODS website averaged more than 756,000 visits per month and more than 1,291,000 page-views per month.
  • In 2018, ODS responded to 565 public inquiries and about two-thirds of these inquiries pertained to vitamins and minerals.
  • In 2018, more than 20 interviews were given to a wide variety of consumer and health professional media outlets. ODS has 6,857 likes and 6,901 people following on Facebook and 14,600 Twitter followers.
  • ODS hosted ten research investigators through its seminar series and an additional five other workshops or expert panel meetings throughout the year.
  • ODS organized two meetings of the Federal Working Group on Dietary Supplements (March 2018, and October 2018) that included presentations and discussions on dietary supplement ingredient identification and characterization, an update of the nutrition and supplement facts labels, an update on DSLD, and the botanical review team's regulatory and scientific experience on botanical drug products. 
    dr betz

  • ODS staff contributed to the development of a Nutrition Research Strategic Plan as part of the NIH Nutrition Research Task Force.
  • ODS communicates nutrition news to NIH and other federal agencies using regular reporting vehicles and by participating in trans-NIH and trans-HHS collaborations.
  • ODS Communications products include the ODS Update (4,454 subscribers), The Scoop: (4,590 subscribers) and videos including: Dietary Supplements: What You Need to Know (24,490 views since posted online in June 2014), Thinking About Taking a Dietary Supplement? (21,335 views since posted online in May 2014), and ¿Debería tomar suplementos dietéticos? (13,202 views since posted online in June 2014).
  • Along with numerous ODS-sponsored presentations by staff, there were 34 ODS staff presentations at national and international workshops, meetings, and conferences and 40 staff publications between January 2018 and December 2018.